Abstract
The rapid spread of SARS-CoV-2 in early 2020 forced provincial health authorities across Canada to quickly institute infection control measures. It is now four years since the start of the global pandemic, and an opportune time to consider how Canada’s provinces compared in their SARS-CoV-2 containment policies and the resulting impacts on mortality and economic activity. I compare provincial exposure to SARS-CoV-2 using data on the number out-of-province arrivals into each province. I compare the key containment measures used in each province, the length of time that these measures were imposed, and the uptake of COVID-19 vaccines by province. Using Statistics Canada data, I also estimate the impact of the COVID-19 pandemic on provincial crude death rates during 2020-2023, and life expectancy and gross domestic product during 2020-2022. I find substantial provincial variation in pandemic responses and outcomes. The provinces varied in their use of the most stringent public health measures. Uptake of the primary COVID vaccinations varied from 76% to 92%; booster vaccination uptake varied even more. There was also marked provincial variation in mortality and economic outcomes. While this study does not estimate the impacts of provincial response stringency and COVID vaccine uptake on mortality and other outcomes, it does provide suggestive evidence that can be formally assessed in future research.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Research is exempt from ethics oversight because it uses publicly available aggregated health statistics.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data used in this study are publicly available online. If the study is accepted for publication in PLOS ONE, the data will also be published in Borealis, a public data repository.
https://doi.org/10.25318/1310083701-eng
https://doi.org/10.25318/1710000501-eng
https://doi.org/10.25318/1310076801-eng
https://doi.org/10.25318/1310078401-eng
https://doi.org/10.25318/3610022201-eng
https://doi.org/10.34989/SAN-2021-1
https://health-infobase.canada.ca/src/data/covidLive/covid19-download.csv
https://health-infobase.canada.ca/covid-19/vaccination-coverage/
https://odesi.ca/en/details?id=/odesi/doi__10-5683_SP3_LEVP0M.xml